MCKMCKESSON CORP

NYSE mckesson.com


$ 503.95 $ -10.58 (-2.06 %)    

Friday, 06-Sep-2024 15:59:56 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 504.17
$ 516.13
$ 499.94 x 100
-- x --
$ 503.34 - $ 518.24
$ 411.17 - $ 636.70
1,924,323
na
65.38B
$ 0.69
$ 22.10
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-K
3 02-07-2024 12-31-2023 10-Q
4 11-01-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-K
7 02-02-2023 12-31-2022 10-Q
8 11-02-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-K
11 02-02-2022 12-31-2021 10-Q
12 11-01-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-K
15 02-02-2021 12-31-2020 10-Q
16 11-03-2020 09-30-2020 10-Q
17 08-03-2020 06-30-2020 10-Q
18 05-22-2020 03-31-2020 10-K
19 02-04-2020 12-31-2019 10-Q
20 10-30-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-K
23 01-31-2019 12-31-2018 10-Q
24 10-25-2018 09-30-2018 10-Q
25 07-26-2018 06-30-2018 10-Q
26 05-24-2018 03-31-2018 10-K
27 02-01-2018 12-31-2017 10-Q
28 10-27-2017 09-30-2017 10-Q
29 07-27-2017 06-30-2017 10-Q
30 05-22-2017 03-31-2017 10-K
31 01-26-2017 12-31-2016 10-Q
32 10-27-2016 09-30-2016 10-Q
33 07-27-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-K
35 01-27-2016 12-31-2015 10-Q
36 10-29-2015 09-30-2015 10-Q
37 07-29-2015 06-30-2015 10-Q
38 05-12-2015 03-31-2015 10-K
39 02-05-2015 12-31-2014 10-Q
40 10-28-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 leerink-partners-maintains-outperform-on-mckesson-lowers-price-target-to-665

Leerink Partners analyst Michael Cherny maintains McKesson (NYSE:MCK) with a Outperform and lowers the price target from $67...

 mckesson-sees-q2-fiscal-2025-adj-eps-to-be-in-range-of-670-700-vs-739-est-reaffirms-fy25-adj-eps-guidance-in-range-of-3175-3255-vs-3221-est

- SEC Filing 

 mckesson-agrees-to-sell-its-canada-based-rexall-and-wellca-businesses-to-birch-hill-equity-partners-no-terms-disclosed

McKesson Canada will continue to own and operate Rexall and Well.ca until transaction close, which is subject to customary clos...

 opioid-settlement-drug-distributors-mckesson-cencora-cardinal-health-to-pay-300m-to-health-insurers

Three major U.S. drug distributors, McKesson, Cencora, and Cardinal Health, have agreed to a $300 million settlement over claim...

 mckesson-inks-definitive-deal-to-acquire-controlling-interest-in-core-ventures-for-approximately-249b-in-cash-which-will-represent-70-ownership

FCS physicians will continue to retain a minority interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core ...

 mckesson-in-talks-for-stake-in-florida-cancer-specialists-florida-cancer-specialists-stake-could-fetch-35b-mckesson-has-been-competing-with-other-bidders-for-stake---bloomberg-news

https://www.bloomberg.com/news/articles/2024-08-23/mckesson-nears-deal-for-stake-in-florida-cancer-chain?utm_content=business&a...

 jp-morgan-maintains-overweight-on-mckesson-raises-price-target-to-661

JP Morgan analyst Lisa Gill maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $656 to $661.

 warner-bros-airbnb-and-monster-beverage-are-among-top-10-large-cap-losers-last-week-aug-4-aug-10-are-the-others-in-your-portfolio

These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. be...

 barclays-maintains-overweight-on-mckesson-raises-price-target-to-616

Barclays analyst Steve Valiquette maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $596 to $...

 evercore-isi-group-maintains-outperform-on-mckesson-lowers-price-target-to-630

Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and lowers the price target fr...

 baird-maintains-outperform-on-mckesson-lowers-price-target-to-671

Baird analyst Eric Coldwell maintains McKesson (NYSE:MCK) with a Outperform and lowers the price target from $694 to $671.

 mckesson-sees-fy25-adj-eps-3175-3255-vs-3174-estimate

Fiscal 2025 Outlook:•Adjusted Earnings per Diluted Share guidance range raised to $31.75 to $32.55, from the previous range of ...

 mckesson-q1-2025-adj-eps-788-beats-721-estimate-sales-7930b-miss-8253b-estimate

McKesson (NYSE:MCK) reported quarterly earnings of $7.88 per share which beat the analyst consensus estimate of $7.21 by 9.29 p...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION